ANDERSON ET AL: "Guidelines on the Use of Intravenous Immune Globulin for Hematologic Conditions", TRANSFUSION MEDICINE REVIEWS, GRUNE AND STRATTON, ORLANDO, FL, US, vol. 21, 28 March 2007 (2007-03-28), pages S9-S56, XP005937815, ISSN: 0887-7963, DOI: 10.1016/J.TMRV.2007.01.001 (B1)

ANN GARDULF ET AL: "Rapid Subcutaneous IgG Replacement Therapy is Effective and Safe in Children and Adults with Primary Immunodeficiencies-A Prospective, Multi-National Study" JOURNAL OF CLINICAL IMMUNOLOGY, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 26, no. 2, 26 April 2006 (2006-04-26) , pages 177-185, XP019400116 ISSN: 1573-2592 cited in the application (B1)

Anonymous: "GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10%" Baxter April 2005 (2005-04), pages 1-4, XP002542175 Retrieved from the Internet: URL:http://www.baxter.com/products/biophar maceuticals/downloads/gamliquid_PI.pdf> [retrieved on 2009-08-20] (B1)

BOOKBINDER L H ET AL: "A recombinant human enzyme for enhanced interstitial transport of therapeutics" JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 114, no. 2, 28 August 2006 (2006-08-28), pages 230-241, XP024957594 ISSN: 0168-3659 [retrieved on 2006-08-28] (B1)

FEASBY ET AL: "Guidelines on the Use of Intravenous Immune Globulin for Neurologic Conditions", TRANSFUSION MEDICINE REVIEWS, GRUNE AND STRATTON, ORLANDO, FL, US, vol. 21, 28 March 2007 (2007-03-28), pages S57-S107, XP005937816, ISSN: 0887-7963, DOI: 10.1016/J.TMRV.2007.01.002 (B1)

WO-A1-2006/091871 (B1)

JOSEPH A CHURCH ET AL: "Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency" JOURNAL OF CLINICAL IMMUNOLOGY, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 26, no. 4, 17 May 2006 (2006-05-17), pages 388-395, XP019400139 ISSN: 1573-2592 (B1)

LEESCH V W ET AL: "30-Day Pharmacokinetic Evaluation of IV versus Subcutaneous Administration of Immunoglobulin with and without Recombinant Human Hyaluronidase in Dogs" JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 123, no. 2, Suppl. S, February 2009 (2009-02), page S10, XP002541722 & 65TH ANNUAL MEETING OF THE AMERICAN-ACADEMY-OF-ALLERGY-ASTHMA-AND-IMM UNOLOGY; WASHINGTON, DC, USA; MARCH 13 -17, 2009 ISSN: 0091-6749 (B1)

MELAMED I R ET AL: "Recombinant human hyaluronidase facilitates dispersion of subcutaneously administered Gammagard liquid and enables administration of a full monthly bose in a single site to patients with immunodeficiency diseases" JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 121, no. 2, Suppl. 1, February 2008 (2008-02), page S83, XP002541721 & 64TH ANNUAL MEETING OF THE AMERICAN-ACADEMY-OF-ALLERGY-ASTHMA-AND-IMM UNOLOGY; PHILADELPHIA, PA, USA; MARCH 14 -18, 2008 ISSN: 0091-6749 (B1)

PRINS CHRISTA ET AL: "Intravenous immunoglobulin: properties, mode of action and practical use in dermatology.", ACTA DERMATO-VENEREOLOGICA 2007, vol. 87, no. 3, 2007, pages 206-218, ISSN: 0001-5555 (B1)

HANS D OCHS ET AL: "Safety and Efficacy of Self-Administered Subcutaneous Immunoglobulin in Patients with Primary Immunodeficiency Diseases" JOURNAL OF CLINICAL IMMUNOLOGY, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 26, no. 3, 2 June 2006 (2006-06-02), pages 265-273, XP019400135 ISSN: 1573-2592 cited in the application (B1)